Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform
Go back to Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform| (NASDAQ: FHTX) | Delayed: 4.14 -0.06 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.20 | 52 Week High | $ | |||
| Open | $4.21 | 52 Week Low | $ | |||
| Day High | $4.25 | P/E | N/A | |||
| Day Low | $4.07 | EPS | $ | |||
| Volume | 502,031 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1152.93 +0.49 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1152.44 | 52 Week High | $88.16 | |||
| Open | $1150.00 | 52 Week Low | $67.88 | |||
| Day High | $1157.60 | P/E | 266.88 | |||
| Day Low | $1140.27 | EPS | $4.32 | |||
| Volume | 4,549,709 | |||||

